International Journal of Ayurveda and Pharma Research https://ijapr.in/index.php/ijapr <div align="justify"> <p class="para1"><strong>International Journal of Ayurveda and Pharma Research (IJAPR)</strong>&nbsp;is an international peer reviewed Monthly open access Online and Print journal. The aim of the journal is to increase the impact of research in both academic and industry, with strong emphasis on quality and originality. The journal promotes to publish the articles in the field of&nbsp;<strong>Ayurveda, Siddha, Yoga, Naturopathy, Unani, Homeopathy and Allopathy</strong>&nbsp;systems of medicine and Pharmaceutical Sciences. Researchers may submit (1). Original Research Articles (2). Review articles (3). Book Reviews (4). Short Communications/ Research Letter (5). Case Report (6). Letter to the Editor/Correspondence.</p> </div> en-US ijaprs@gmail.com (Dr B Srinivasulu M.D (Ayu.)) ijaprs@gmail.com (V Sowmya) Fri, 12 Feb 2021 03:22:53 +0800 OJS 3.1.2.1 http://blogs.law.harvard.edu/tech/rss 60 ROLE OF ARKA TAILA AND BAAKUCHIKADYAM CHURNA ON VICHARCHIKA: A RANDOMIZED CONTROL TRIAL https://ijapr.in/index.php/ijapr/article/view/1759 <p>In the present era skin diseases like atopic dermatitis/eczema get a suitable atmosphere especially in developing countries like India, due to unhygienic living condition, Disturbed life style, Polluted environment and repeated use of chemical additives. This type of diseases make a person feels much more humiliation in society because no one wants to touch them, forbidden by everyone, in that conditions person leads to lack of confidence and feels underestimated mentally as well as physically. Due to this life disturbing condition this disease was chosen for the study.</p> <p>The study was conducted in 30 clinically diagnosed patients of <em>Vicharchika</em> (Atopic Dermatitis) and randomly divided in to two groups, namely group A and group B. Each group has 15 number of patients. Group A is treated with <em>Arka Taila</em> (external application) used twice in a day for 45 days along with <em>Baakuchikadyam Churna</em> for internal consumption (3-6 grams). Group B is treated with Cutis Capsule (2 Capsules) twice a day orally along with external application of Cutis Cream as required for 45 days.</p> Sheetal Yadav, Anita Sharma, Dinesh C. Chouhan Copyright (c) 2021 International Journal of Ayurveda and Pharma Research https://creativecommons.org/licenses/by-nc-sa/4.0 https://ijapr.in/index.php/ijapr/article/view/1759 Tue, 09 Feb 2021 00:00:00 +0800 EVALUATION OF THE TREATMENT OF SHWITRA WITH AYURVEDA MODALITIES: A CASE STUDY https://ijapr.in/index.php/ijapr/article/view/1764 <p>In Ayurveda most of the skin diseases are explained under the term <em>Kushtha. Shwitra</em> is considered as one of the varieties of <em>Kushtha</em> in the Ayurvedic Classics, caused vitiation of <em>Tridoshas</em> and <em>Dhatus</em> like <em>Rakta, Mamsa</em> and <em>Meda</em>. The references of Shwitra are found in almost all the Samhitas like Bruhatrayees and Laghutrayees. Partial or complete loss of skin pigmentation giving rise to white patch on any part of the body is called as leucoderma or vitiligo and in Ayurveda it is called as <em>Shwitra</em>. This depigmentation results due to destruction of melanocytes, which may be unknown in origin or due to autoimmune endocrinopathies selective IgA deficiency. A female patient, aged 20 year suffering from white patches in neck region since 4 year was treated with both <em>Shaman Chikitsa</em> and <em>Sodhan Chikitsa</em> for a period to 4 months with follow up at every 30 days in between, Relief from the complaints was assessed by noting the changes in the size of patch. After 4 months of treatment the size of patch was reduced. The present case study revealed the efficacy of Ayurveda therapy both internal and external for duration of 4 months in the management of <em>Shwitra</em>.</p> Verma Priyanka, Lahange M. Sandeep, Jain Saurabh, Sharma Dushyant Copyright (c) 2021 International Journal of Ayurveda and Pharma Research https://creativecommons.org/licenses/by-nc-sa/4.0 https://ijapr.in/index.php/ijapr/article/view/1764 Tue, 09 Feb 2021 00:00:00 +0800 PRELIMINARY PHARMACOGNOSTICAL, PHYTOCHEMICAL STUDY AND HPTLC ANALYSIS OF COSTUS PICTUS D.DON. https://ijapr.in/index.php/ijapr/article/view/1765 <p>The ancient wisdom in Ayurveda medicine is still not exhaustively explored. Multiple exotic plants existent in India which are not described in classical literature of Ayurveda are commonly referred to as&nbsp;<em>Anukta Dravya</em>&nbsp;(undocumented). <em>Costus</em> <em>pictus</em> D.Don is such a plant, recently introduced in India from Mexico, which is used for renal disorders there. In India, it is used in Diabetes mellitus. This is proven for antidiabetic, antioxidant, anticancerous, antimicrobial and diuretic actions. It is an easily propagated, palatable and cost effective plant. Identification through pharmacognostical and phytochemical studies is essential for the standardization of any plant. The green leaf is narrowly elliptic with 10 to 25cm length and 2.5 to 6cm width. Microscopy revealed presence of vascular bundles, unicellular trichomes in upper epidermis, thin walled parenchyma cells in ground tissue and layers of parenchymatous hypodermis. Powder microscopy showed presence of epidermal parenchyma cells with underlying chlorenchyma group of fibers and fibro vascular bundles.TLC photo documentation revealed presence of many phytoconstituents with different Rf values. Densitometric scan showed many peaks, 10 at 254nm, 11 at 366nm, 6 at 520nm and 9 at 620 nm after derivatisation. Moisture content was 20%. The percentage of total ash, acid insoluble ash, and water insoluble ash was determined. The water soluble extractive value was 22.57 which is highest among all the extracts. The results indicated the presence of alkaloid, steroids, tannins, flavanoids, phenol, carbohydrate and resin in ethanolic extract and steroid, flavanoids, phenols, saponins, tannins and glycosides in water extract<em>.</em></p> Hasna.T, Vivek.P, Manojkumar.N Copyright (c) 2021 International Journal of Ayurveda and Pharma Research https://creativecommons.org/licenses/by-nc-sa/4.0 https://ijapr.in/index.php/ijapr/article/view/1765 Tue, 09 Feb 2021 00:00:00 +0800 PHARMACEUTICO-ANALYTICAL STUDY OF CHAUSATHPRAHARI PIPPALI CHURNA https://ijapr.in/index.php/ijapr/article/view/1766 <p><em>Ayurvedic</em> pharmaceutics is one of the fastest growing sectors in the world market. Globalization expects pharmaceutical standardization. Competition in pharma industry expects good quality products which have documentation regarding safety and efficacy issues. Ancient heritage blended with current updated pharmaceutical technology helps in better appreciation. <em>Chausath Prahari Pippali Churna </em>is a classical <em>Ayurvedic </em>formualtion mentioned in <em>Ayurvedsarasa</em><em>m</em><em>ghraha</em> a renowned text of Ayurveda, which is useful in <em>Vata</em> and <em>Kapha</em> diseases. It has potent herbal remedy for both respiratory and digestive disorders. It is prepared by <em>Bhavana</em> with <em>Phanta </em>(hot infusion) of <em>Badi</em><em>pippali </em>to <em>Chhotipippalichurna </em>upto 64 <em>Prahar</em> (192hrs) to make it more strong and efficient formulation. The attempt is made in the present article to assess its pharmacological action and analytical aspect while processing the drug – <em>Chausath Prahari Pippali Churna</em> (CPP).</p> Rajendra Barfa, Vijay Shreebharti, Amit Mishra, Dimpal Sharma, Amit Kumar Sharma, Sanjay Kumar Copyright (c) 2021 International Journal of Ayurveda and Pharma Research https://creativecommons.org/licenses/by-nc-sa/4.0 https://ijapr.in/index.php/ijapr/article/view/1766 Tue, 09 Feb 2021 00:00:00 +0800 REVIEW OF HARITAKI (TERMINALIA CHEBULA Retz.) AS AN EKAL DRAVYA CHIKITSA IN BRIHATRAYEE https://ijapr.in/index.php/ijapr/article/view/1762 <p>Ayurveda is a traditional system of Indian medicine which aims to promote health and wellness by maintaining equilibrium of all three <em>Dosas</em> of body. Natural medicinal herbs are an important component of this science which aims to protect the body from various ailments and offer an user a variety of health benefits including physical as well as mental health. <em>Haritaki</em> has been placed in high esteem among all medicinal herbs due to its rich property to prevent and cure disease. It is always listed first in Ayurveda as it is called the king of medicines due to its large number of uses having extraordinary therapeutic benefits. Since ancient time, <em>Haritaki</em> has enjoyed a prime place among all medicinal plants. It is being found to be used in many of compound formulations due to its wide spectrum of pharmacological activities. <em>Haritaki</em> is one of three dried fruits that make up the Ayurvedic formula <em>Triphala</em>. It has been used among the large number of population to promote healing from variety of diseases ranging from use as <em>Rasayan</em> to the diseases related to indigestion and many more. <em>Haritaki </em>is being used as a best prescribed remedy for many of the common ailments in day today’s life by large number of physician. It is being used easily in all diseases, either for its health promoting benefit or for its disease alleviating property. Nowadays, using <em>Haritaki</em> as a single <em>Dravya</em> with various <em>Anupaan</em> is a great trend giving optimum results. <em>Ekaldravya</em> concept of using single substances has been mentioned in our ancient Ayurvedic literature. Use of <em>Haritaki</em> as a single drug therapy has been evidenced at various instances in <em>Brihatrayee</em>.</p> Singh Rajani, Rath Sudipta Kumar Copyright (c) 2021 International Journal of Ayurveda and Pharma Research https://creativecommons.org/licenses/by-nc-sa/4.0 https://ijapr.in/index.php/ijapr/article/view/1762 Tue, 09 Feb 2021 00:00:00 +0800 COMBINED EFFECT OF SNEHANA WITH PIPPALYADIANUVASANA THAILA AND VIRECHANA WITH HINGUTHRIGUNA THAILA IN POLYCYSTIC OVARIAN SYNDROME https://ijapr.in/index.php/ijapr/article/view/1767 <p>The polycystic ovarian syndrome is the leading cause of female infertility in the present scenario. It is one of the top reproductive endocrine disorders in the world. In the conventional method, no definite treatment is proven for this ailment and it mainly depends upon hormonal preparations and invasive techniques. These modalities are costlier and have many side effects. In Polycystic ovarian syndrome, there is<em>Nashtarthava</em>&nbsp;which means the loss of ovulation as well as menstruation.&nbsp;<em>Kapha Vatha</em>&nbsp;<em>Avarana&nbsp;</em>causing<em>&nbsp;Artavanasha</em>&nbsp;which is explained as&nbsp;<em>Nashtarthava</em> by <em>Susrutha</em>&nbsp;can also be considered in this particular disease.&nbsp;<em>Vatha</em>&nbsp;is the cardinal <em>Dosha</em> vitiated in all these conditions. So the treatment modalities which correct&nbsp;<em>Vathavaigunya</em>&nbsp;can be adopted here. By considering the above facts <em>Snehana</em> with <em>Pippalyadi anuvasana thaila</em> and <em>Virechana</em> with <em>Hingutriguna thaila</em> were selected. These treatment modalities help in correcting <em>Mootavatha</em>&nbsp;and thereby removing <em>Arthavavaha srothorodha</em>. The study design was a pre and post interventional study with a sample size of 30. Females in the age group 18-38 years with Polycystic Ovarian syndrome attending the outpatient and inpatient department of Govt Ayurveda College hospital for women and children Poojappura, was selected for study as per Rotterdam Criteria. The symptoms were assessed before starting treatment using a case proforma, ultra-sonogram, and necessary lab investigations. The assessment was done each month during the study period and the follow-up period. Data obtained was analyzed statistically. The treatment was found to be effective in normalizing menstrual intervals, reducing the volume of ovaries, and reducing the body mass index. It was not effective in reducing the number of follicular cysts and in the induction of ovulation within the study period.</p> Athira Raj, Asha S T, Shiny S Raj Copyright (c) 2021 International Journal of Ayurveda and Pharma Research https://creativecommons.org/licenses/by-nc-sa/4.0 https://ijapr.in/index.php/ijapr/article/view/1767 Tue, 09 Feb 2021 00:00:00 +0800 ROLE OF BASE PLATFORM TO PREPARE PARPATI KALPANA W.S.R. TO RASA PARPATI https://ijapr.in/index.php/ijapr/article/view/1769 <p><em>Parpati Kalpana</em> is one of the famous <em>Kalpanas</em> of <em>Rasashastra </em>which is widely used and considered as a boon for digestive disorders. The <em>Parpati</em> name is given to this <em>Kalpana</em> as per its <em>Papad</em> or <em>Parpata</em> – thin flake – like appearance. <em>Parpati Kalpana </em>is mainly divided into <em>Sagandha</em> and <em>Nirgandha Parpati Kalpana. Rasa Parpati</em> is the type of <em>Sagandha Parpati Kalpana.</em> To prepare <em>Parpati kalpana</em>, at least one ingredient should get liquefied at normal heating and should get solidified when it gets cooled down, not only that, to get the thin flake like structure specific pressure needs to be applied. In present study <em>Rasa Parpati </em>was prepared by using <em>Samaguna Kajjali</em> (Equal quantity of <em>Parada</em> and <em>Gandhaka</em>) and to check the cooling effect and the role of base platform; here three different platforms were made i.e. cow dung and wet clay mixed platform, only wet clay platform (Earthen platform) and ice block platform. Total nine samples of <em>Rasa Parpati</em> were prepared, three on each platform to check which platform is convenient to prepare <em>Rasa Parpati. </em>The average thickness of <em>Rasa Parpati</em> was found minimum (2.83 mm) on cow dung and wet clay mixed platform whereas the maximum (4 mm) on ice block platform i.e. 4 mm. Average thickness of <em>Rasa Parpati </em>made on earthen platform was 3.57 mm which is thicker than the Cow dung and wet clay mixed platform and thinner than the ice cube platform. Which indicates the best platform to make thinnest <em>Parpati </em>is cow dung and wet clay mixed platform.</p> Mamta Parikh, Prajapati Pradeep Kumar Copyright (c) 2021 International Journal of Ayurveda and Pharma Research https://creativecommons.org/licenses/by-nc-sa/4.0 https://ijapr.in/index.php/ijapr/article/view/1769 Tue, 09 Feb 2021 00:00:00 +0800 PITTAJA ARTAVADUSHTI AND ITS TREATMENT: A CASE STUDY https://ijapr.in/index.php/ijapr/article/view/1709 <p>In order to give rise to new offspring, female body undergoes menstrual cycle. It involves the shedding of endometrium manifested as <em>Māsānumāsika Rajaḥ Pravṛtti </em>i.e., <em>Ārtava Pravṛtti. </em>Due to changes in life style of women in terms of <em>Āhāra</em>, <em>Vihāra</em>, there is more physical and emotional stress and this may result in <em>Ārtavaduṣṭi, </em>where the normal menstrual cycle gets disturbed or presented in altered form.</p> <p><strong>Background:</strong> A married Hindu female patient of 35 years came to NIA <em>Prasuti-stree Roga</em> OPD on 25<sup>th</sup> July, 2019 with complaints of painful menstruation since last 14 years, heavy bleeding during menstruation since last 10 years and mild burning micturition with increased frequency of micturition (on/off) since last 2 years.</p> <p><strong>Methodology: </strong>Mainly <em>Pitta Doṣa</em> vitiation symptoms were observed in the patient. Her complete <em>Nidāna Parivarjana </em>and <em>Prakṛti Vighāta</em> was done and <em>Pitta Doṣa Śāmaka Dravyas</em> were used in treatment including specific <em>Pittaja Ārtavaduṣṭi </em>line of treatment mentioned in Ayurvedic classics. She was given combination of <em>Yaṣṭīmadhu Cūrṇa</em>, <em>Miśi </em>(Fennel), <em>Munakkā</em> (dried <em>Vitis vinifera</em>), <em>Goghṛta</em> twice a day in the form of <em>Kalka </em>with warm water, <em>Kuṭakī Cūrṇa, Munakkā, Dhāgā Miśrī</em> in equal parts in the form of pea sized <em>Guṭikā</em> twice a day with cold water, <em>Gokṣura Cūrṇa, Copcīnī Cūrṇa</em> twice a day with water, <em>Avipattikara Cūrṇa </em>before meal, twice a day with water. The treatment was continued for 2 months.</p> <p><strong>Result:</strong> There was relief in menstrual and urinary symptoms after 2 months of treatment.</p> Shalvi Sharma, Dave Hetal H, Bharathi K, Choudhary Poonam, Dash Bhagyaranjan Copyright (c) 2021 International Journal of Ayurveda and Pharma Research https://creativecommons.org/licenses/by-nc-sa/4.0 https://ijapr.in/index.php/ijapr/article/view/1709 Tue, 09 Feb 2021 00:00:00 +0800 PRELIMINARY EVIDENCE ON EFFECTIVENESS OF RAKTDA (MA 321), AN AYURVEDIC SUPPLEMENT, FOR OPTIMUM MANAGEMENT OF ANAEMIA – A SHORT REVIEW https://ijapr.in/index.php/ijapr/article/view/1771 <p>Despite multiple nutritional programmes and iron supplementation therapies adopted over the past 50 years, Anaemia remains a highly prevalent condition in India. The underlying pathogenesis associated with Anaemia includes not only nutritional deficiencies, but also the issues with optimum absorption, bioavailability of food nutrients, and assimilation of absorbed nutrients. The current review comprises preliminary evidence on <em>Raktda</em> (MA 321), an Ayurvedic supplement for adjuvant or monotherapy use in long term treatment of Anaemia. <em>Raktda</em> has a holistic combination of ingredients including <em>Mandoor Bhasma</em>, <em>Kant Lauh Bhasma</em>, <em>Praval Pishti</em>, <em>Muktashukti Pishti, Giloy Sattva, Yashtimadhu, Shilajit, Amalaki</em> and many other herbs traditionally useful for treating all types of Anaemia and its associated morbidities. The synergy of herbs in <em>Raktda</em> reinstates normal physiology by functioning at five different levels: <em>Agni, Pitta Dosha, Rasa Dhatu, Rakta Dhatu, </em>and<em> Rasayana. </em>A small sample study (n = 16) on <em>Raktda</em> has shown an increase in mean Hb% from 9.231 to 11.046 (paired t-value= 8.5475, SE = 0.212, p&lt;0.0001) - a change of mean by 1.815 points (95% CI = 1.353- 2.278), within a period of 30 days. Another study on <em>Raktda</em> (n = 47) has shown the beneficial effects of <em>Raktda</em> on increasing Hb% (7.16 to 11.13) and other anaemia symptoms such as fatigue, pain in legs, narcolepsy, anorexia, and faintness of skin. The current review outlines the need for conducting large scale investigations on <em>Raktda</em>, which can be used for treating Anaemia in the long run.</p> Sanjay Chhajed, Rini Vohra, Anand Shrivastava Copyright (c) 2021 International Journal of Ayurveda and Pharma Research https://creativecommons.org/licenses/by-nc-sa/4.0 https://ijapr.in/index.php/ijapr/article/view/1771 Tue, 09 Feb 2021 00:00:00 +0800 AYURVEDIC APPROACH TO MANAGE PCOS RELATED PRIMARY INFERTILITY: A CASE STUDY https://ijapr.in/index.php/ijapr/article/view/1772 <p>Infertility is defined as when a couple failed to conceive within one or more years of regular unprotected coitus. Primary infertility denotes those patients who have never conceived. Secondary infertility denotes previous pregnancy but failure to conceive subsequently. 80% of the couples achieve conception if they so desire, within one year of having regular intercourse with adequate frequency. Another 10% will achieve the objective by the end of second year. As such, 10% remain infertile by the end of second year. Now days, PCOS is one of the most common cause of infertility in women. In PCOS the hormonal imbalance interferes with the development and release of ovum from the ovaries. PCOS manifested by amenorrhoea, hirsutism and obesity associated with enlarged polycystic ovaries. PCOS is characterised by excessive androgen production by ovaries and adrenals which interferes with growth of the ovarian follicles. Therefore PCOS is a state of androgen excess and chronic anovulation. A 27 years old female visited OPD of PTSR NIA with complaints of wants issue since two years. After thorough examination, she was diagnosed as PCOS in Ultrasonography. At first, medicine for withdrawal bleeding was given. Then <em>Shatapushpa</em> <em>churna</em> and <em>Phalasarpi</em> was given for two months and then after she was conceived.</p> Susheela Choudhary, Khushboojha, B. Pushpalatha, K. Bharathi Copyright (c) 2021 International Journal of Ayurveda and Pharma Research https://creativecommons.org/licenses/by-nc-sa/4.0 https://ijapr.in/index.php/ijapr/article/view/1772 Tue, 09 Feb 2021 00:00:00 +0800 MANAS (MIND) AND MANOVIKARA (MENTAL DISORDER) IN AYURVEDA: A REVIEW https://ijapr.in/index.php/ijapr/article/view/1773 <p>Ayurveda is thought to be ‘The Science of Life’, and therefore the follow involves the care of physical and mental health of creature. Ayurveda isn’t solely restricted to body or physical symptoms however conjointly provide comprehensive data concerning mental and social health. Three factors are basically responsible for the origin of any kind of disease, these are <em>Asatmaindriyartha Samyoga</em> (excessive utilization or non-utilization or improper utilization of sense faculties), <em>Prajnaparadha</em> (Intellectual blasphemy) and <em>Parinama</em> (time). Balanced <em>Doshas</em> of mind regulates the emotion while disturbed <em>Doshas</em> of mind plays an important role in the pathogenesis of mental diseases. The increasing level of stress in today’s time gives a huge surge of <em>Manovikara</em> (mental disorder). In Ayurveda many references of <em>Manas </em>(mind) and treatment of <em>Manovikara</em> (mental disorder) are available which would be easy to understand and rewarding the field of treatment. Role of <em>Swastavritta</em> including <em>Daivavyapasraya, Satwavajay, Naisthiki chikitsa</em> and <em>Yoga</em> are very important in the management of <em>Manovikara</em>. In modern era we are at the grasp of <em>Raja</em> and <em>Tama</em> which are the root cause of mental disorder. So, it is necessary to understand the <em>Manovikara</em> (mental disorder), its causes, symptoms, prevention and management. Present article is a review article contains review of <em>Manas</em> (Mind) and <em>Manovikara</em> (Mental disorder) in Ayurveda.</p> Trisha Talapatra, Md Tanzil Ansari, Sukumar Ghosh, Rina Ghosh Copyright (c) 2021 International Journal of Ayurveda and Pharma Research https://creativecommons.org/licenses/by-nc-sa/4.0 https://ijapr.in/index.php/ijapr/article/view/1773 Tue, 09 Feb 2021 00:00:00 +0800 EFFECTIVE MANAGEMENT OF ARTAVA KASHAYA BY AYURVEDA: A CASE REPORT https://ijapr.in/index.php/ijapr/article/view/1774 <p>A female patient of 25 years of age came to OPD of National institute of Ayurveda, Jaipur on 22 September, 2020 with chief complaint of delayed menstruation with scanty flow since 4.5 years. <strong>Methodology</strong>: Detailed history with all necessary clinical, physical examination and laboratory investigations were carried out. No gross physical and chemical abnormality was found. All the laboratory investigations (including USG and hormonal analysis) were found to be normal. So the treatment was planned according to the symptoms. Diagnosis made on the basis on the basis of presenting complaints was <em>Artava kashaya</em>. Patient was treated with <em>Tilashelukaravi kwatha</em> for 2 consecutive cycles. Patient was kept on follow up for 1 cycle after cessation of <em>Tilashelukaravi kwatha</em>. <strong>Result: </strong>Patient had got her menstruation regularly with normal duration while taking medicine. Also the amount of flow was also improved and intensity of pain was reduced effectively from moderate to mild. Even after cessation of medicine she got her menstruation in 30 days with normal amount of flow.</p> Poonam Kumari, Hetal H. Dave, Poonam Choudhary, Sonu Copyright (c) 2021 International Journal of Ayurveda and Pharma Research https://creativecommons.org/licenses/by-nc-sa/4.0 https://ijapr.in/index.php/ijapr/article/view/1774 Tue, 09 Feb 2021 00:00:00 +0800 CONCEPT OF POST OPERATIVE PAIN AND ITS MANAGEMENT IN AYURVEDA: A LITERATURE REVIEW https://ijapr.in/index.php/ijapr/article/view/1775 <p>Adequate analgesia in postoperative period is an essential and humanitarian factor for faster recovery. Currently used analgesics are opioids and NSAIDs which have certain adverse effect. So there is need to search pain management measures from alternative science to minimise use of opioids and NSAIDs. <em>Sushruta</em> <em>samhita</em> (Sushruta’s compendium) is the oldest reference for surgery in the world. He did various surgeries including laprotomy for intestinal obstruction, perforation, rhinoplasty, cataract and so many minor surgeries like cyst, lipoma etc removal thousand years back. Certainly he managed postoperative pain also. An effort is made in this article to explore Sushruta concept of postoperative pain and its management. Also currently available online articles regarding postoperative pain management in Ayurveda are searched. By using Ayurvedic protocols, polyherbal formulations effective pain management is possible and use of NSAIDs and opioids can be minimised<em>.</em></p> Dhanokar C.A, Badwe Y.R Copyright (c) 2021 International Journal of Ayurveda and Pharma Research https://creativecommons.org/licenses/by-nc-sa/4.0 https://ijapr.in/index.php/ijapr/article/view/1775 Tue, 09 Feb 2021 00:00:00 +0800 GUDA VARTI FOR POST-OPERATIVE PAIN MANAGEMENT- ROAD LESS TRAVELLED https://ijapr.in/index.php/ijapr/article/view/1539 <p>Acute pain is an unpleasant sensory, emotional and mental sensation (experience) associated with vegetative signs, psychological response and changes in behavior. Post-operative pain is one such example and adequate management becomes utmost necessary. In Shalya tantra practice, proctology is the field of excellence for many practitioners and post-operative pain is an acquaintance difficult to handle. Many practitioners still resort to using contemporary I.M OR I.V analgesics for pain management which have proven ADR’S due to lack of availability of Ayurvedic analgesics for management. <em>Vartis</em> (suppositories) was in vogue since pre-historic times and have been mentioned in almost all Ayurvedic texts for various disorders with suitable formulations and various modes of insertion, e.g.: <em>Ratadi varti </em>for<em> Shoola</em>. Ayurveda also has a wide-range of drugs mentioned for relieving pain which have not been used to the full potential. Hence <em>Guda varti</em> as a drug delivery system for pain management needs to be explored in Ayurveda <em>Shalya tantra</em> practice<em>.</em></p> Vilas Thakre Kalpita, P Bhat Ramesh Copyright (c) 2021 International Journal of Ayurveda and Pharma Research https://creativecommons.org/licenses/by-nc-sa/4.0 https://ijapr.in/index.php/ijapr/article/view/1539 Wed, 10 Feb 2021 00:00:00 +0800 IN VITRO ANTIBACTERIAL EFFECT OF AQUEOUS EXTRACT OF SIDDHARTAKA SNANA USED IN TREATMENT OF VICARCHIKA (ECZEMA) https://ijapr.in/index.php/ijapr/article/view/1779 <p><em>Vicarchika</em> is a type of <em>Kushta Roga</em> (skin disease). It can be correlated with eczema. <em>Staphylococcus aureus, Escherichia coli, </em><em>Pseudomonas aeruginosa</em> are some of the bacteria which cause skin diseases. Siddhartaka Snana is a herbal bath that is described in Charaka Samhita as a treatment for <em>Kushta Roga. Siddhartaka Snana</em> is a herbal preparation which consists ten herbs namely; <em>Cyperus rotundus</em>, <em>Catunaregum spinosa</em>, <em>Phyllanthus emblica</em>, <em>Terminalia chebula</em>, <em>Terminalia bellarica,</em> <em>Cassia fistula</em>, <em>Pongamia pinnata</em>, <em>Holarrhena antidysentrica</em>, <em>Alastonia scholaris </em>and <em>Coscinum fenestratum</em>. Antibacterial effect of <em>Siddhartaka Snana</em> against <em>Staphylococcus aureus, Escherichia coli, </em><em>Pseudomonas aeruginosa</em> that are responsible for skin diseases was studied using disc diffusion method and well diffusion methods. In disc diffusion method, no inhibition zone was observed with any of the tested bacteria. However, an inhibition zone of 9.67mm was observed against <em>Staphylococcus aureus</em> in well diffusion method with <em>Siddhartaka Snana.</em> Minimum Inhibitory Concentration (MIC) of <em>Siddhartaka Snana</em> against <em>Staphylococcus aureus</em> <em>was </em>0.9225 mg/1ml. Ingredients of <em>Siddhartaka Snana</em> contain tannins, phenols and flavonoids, all of which possess antibacterial properties. Antibacterial effect of <em>Siddhartaka Snana</em> may have been exhibited due to actions of these phytochemicals. It was concluded that <em>Siddhartaka Snana</em> has an antibacterial effect against <em>Staphylococcus aureus</em>.</p> E.R.H.S.S. Ediriweera, A.M.H.Y Perera, R. Senavirathne, R. Rajapaksha Copyright (c) 2021 International Journal of Ayurveda and Pharma Research https://creativecommons.org/licenses/by-nc-sa/4.0 https://ijapr.in/index.php/ijapr/article/view/1779 Tue, 09 Feb 2021 00:00:00 +0800